The Effect of Losartan and Amlodipine on Left Ventricular Diastolic Function and Atherosclerosis in Japanese Patients with Mild-to-Moderate Hypertension (J-ELAN) study

Hypertension Research

Volumn 34, Issue 3, 2011, Pages 325-330

  Yamamoto, Kazuhiro ^a,b   Ozaki, Hitoshi ^c   Takayasu, Ken ^d   Akehi, Noriyuki ^e   Fukui, Sugao ^f   Sakai, Akihiko ^g   Kodama, Mineo ^h   Shimonagata, Tsuyoshi ⁱ   Kobayashi, Keiji ^j   Ota, Mitsushige ^k   Horiguchi, Yasunori ^l   Ebisuno, Shoji ^m   Katsube, Yoshiki ⁿ   Yamazaki, Tsutomu ^o   Ohtsu, Hiroshi ^o   Hori, Masatsugu ^a,p  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA UNIVERSITY   (Japan)

^c Ozaki Clinic   (Japan)

^d Takayasu Clinic   (Japan)

^e Settsu Iseikai Hospital   (Japan)

^f Kawasaki Hospital   (Japan)

^g Sakai Clinic   (Japan)

^h Kodama Clinic   (Japan)

ⁱ Shimonagata Clinic   (Japan)

^j Kobayashi Clinic   (Japan)

^k Ohta Clinic   (Japan)

^l Horiguchi Clinic   (Japan)

^m Ebisuno Clinic   (Japan)

ⁿ Katsube Clinic   (Japan)

^o UNIVERSITY OF TOKYO   (Japan)

^p OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

more..

Author keywords

angiotensin receptor blocker; atherosclerosis; calcium channel blocker; diastolic dysfunction

Indexed keywords

AMLODIPINE; LOSARTAN;

ADULT; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROTIC PLAQUE; BLOOD PRESSURE REGULATION; CAROTID ATHEROSCLEROSIS; CONTROLLED STUDY; DIASTOLIC DYSFUNCTION; DISEASE COURSE; DISEASE SEVERITY; DRUG DOSE TITRATION; DRUG RESPONSE; FEMALE; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HUMAN; HYPERTENSION; JAPANESE; LEFT VENTRICULAR DIASTOLIC FUNCTION; MAJOR CLINICAL STUDY; MALE; PULSE WAVE; RANDOMIZED CONTROLLED TRIAL; SYSTOLE;

ADRENERGIC ALPHA-ANTAGONISTS; AGED; AMLODIPINE; ANGIOTENSIN II TYPE 2 RECEPTOR BLOCKERS; ANTIHYPERTENSIVE AGENTS; ASIAN CONTINENTAL ANCESTRY GROUP; ATHEROSCLEROSIS; CALCIUM CHANNEL BLOCKERS; CAROTID ARTERIES; DIABETES MELLITUS; DIURETICS; DRUG THERAPY, COMBINATION; DYSLIPIDEMIAS; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; LOSARTAN; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT;

EID: 79952407247     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1038/hr.2010.237     Document Type: Article

References (40)

1. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo Jr JL, Jones DW, Materson BJ, Oparil S, Wright Jr JT, Roccella EJ. The seventh report of the Joint Committee on prevention, detection, evaluation, and treatment of high blood pressure. JAMA 2003;289: 2560-2572. (Pubitemid 37430158)
2. Julius S, Alderman MH, Beevers G, Dahlof B, Devereaux RB, Douglas JG, Edelman JM, Harris KE, Kjeldsen SE, Nesbitt S, Randall OS, Wright Jr JT. Cardiovascular risk reduction in hypertensive black patients with left ventricular hypertrophy: the LIFE study. J Am Coll Cardiol 2004;43: 1047-1055. (Pubitemid 38352987)
3. Wright JT, Dunn JK, Cutler JA, Davis BR, Cushman WC, Ford CE, Haywood LJ, Leenen FH, Margolis KL, Papademetriou V, Probstfield JL, Whelton PK, Habib GB. Outcomes in hypertensive black and nonblack patients treated with chlorthalidone, amlodipine, and lisinopril. JAMA 2005;293: 1595-1608. (Pubitemid 40471790)
4. Aurigemma GP, Gottdiener JS, Shemanski L, Gardin J, Kitzman D. Predictive value of systolic and diastolic function for incident congestive heart failure in the elderly: the Cardiovascular Health Study. J Am Coll Cardiol 2001;37: 1042-1048. (Pubitemid 32217604)
5. Bella JN, Palmieri V, Roman MJ, Liu JE, Welty TK, Lee ET, Fabsitz RR, Howard BV, Devereux RB. Mitral ratio of peak early to late diastolic filling velocity as a predictor of mortality in middle-aged and elderly adults: the Strong Heart Study. Circulation 2002;105: 1928-1933. (Pubitemid 34437620)
6. Tsuchihashi-Makaya M, Hamaguchi S, Kinugawa S, Yokota T, Goto D, Yokoshiki H, Kato N, Takeshita A, Tsutsui H. Characteristics and outcomes of hospitalized patients with heart failure and reduced vs preserved ejection fraction -a report from the Japanese Cardiac Registry of Heart Failure in Cardiology (JCARE-CARD). Circ J 2009;73: 1893-1900.
7. O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson Jr SK. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. N Engl J Med 1999;340: 14-22. (Pubitemid 29024679)
8. Lorenz MW, von Kegler S, Steinmetz H, Markus HS, Sitzer M. Carotid intimamedia thickness indicates a higher vascular risk across a wide age range. Prospective data from Carotid Atherosclerosis Progression Study (CAPS). Stroke 2006;37: 87-92. (Pubitemid 43732053)
9. Fernandes VR, Polak JF, Cheng S, Rosen BD, Carvalho B, Nasir K, McClelland R, Hundley G, Pearson G, O'Leary DH, Bluemke DA, Lima JA. Arterial stiffness is associated with regional ventricular systolic and diastolic dysfunction: the Multi-Ethnic Study of Atherosclerosis. Arterioscler Thromb Vasc Biol 2008;28: 194-201.
10. Nishikawa N, Masuyama T, Yamamoto K, Sakata Y, Mano T, Miwa T, Sugawara M, Hori M. Long-term administration of amlodipine prevents decompensation to diastolic heart failure in hypertensive rats. J Am Coll Cardiol 2001;38: 1539-1545. (Pubitemid 33033040)
11. Sakata Y, Masuyama T, Yamamoto K, Doi R, Mano T, Kuzuya T, Miwa T, Takeda H, Hori M. Renin angiotensin system-dependent hypertrophy as a contributor to heart failure in hypertensive rats: different characteristics from renin angiotensin system-independent hypertrophy. J Am Coll Cardiol 2001;37: 293-299. (Pubitemid 32051753)
12. Sakata Y, Yamamoto K, Mano T, Nishikawa N, Yoshida J, Nakayama H, Otsu K, Suzuki K, Tada T, Hori M, Miwa T, Masuyama T. Angiotensin II type 1 receptor blockade prevents diastolic heart failure through modulation of Ca2+ regulatory proteins and extracellular matrix. J Hypertens 2003;21: 1737-1745. (Pubitemid 37076358)
13. The J-ELAN Investigators. The effect of losartan and amlodipine on left ventricular diastolic function in patients with mild-to-moderate hypertension (J-ELAN): rationale and design. Circ J 2006;70: 124-128.
14. Dahlof B, Zanchetti A, Diez J, Nicholls MG, Yu CM, Barrios V, Aurup P, Smith RD, Johansson M. Effects of losartan and atenolol on left ventricular mass and neurohormonal profile in patients with essential hypertension and left ventricular hypertrophy. J Hypertens 2002;20: 1855-1864.
15. Zile MR, Gaasch WH, Carroll JD, Feldman MD, Aurigemma GP, Schaer GL, Ghali JK, Liebson PR. Heart failure with a normal ejection fraction: is measurement of diastolic function necessary to make the diagnosis of diastolic heart failure? Circulation 2001;104: 779-782. (Pubitemid 32762675)
16. Yamaguchi H, Yoshida J, Yamamoto K, Sakata Y, Mano T, Akehi N, Hori M, Lim YJ, Mishima M, Masuyama T. Elevation of plasma brain natriuretic peptide is a hallmark of diastolic heart failure independent of ventricular hypertrophy. J Am Coll Cardiol 2004;43: 55-60. (Pubitemid 38045916)
17. Nishio M, Sakata Y, Mano T, Ohtani T, Takeda Y, Hori M, Yamamoto K. Difference of clinical characteristics between hypertensive patients with and without diastolic heart failure: role of diastolic dysfunction and renal insufficiency. Hypertens Res 2008;31: 1865-1872.
18. Quinones MA, Waggoner AD, Reduto LA, Nelson JG, Young JB, Winters Jr WL, Ribeiro LG, Miller RR. A new simplified and accurate method for determining ejection fraction with two-dimensional echocardiography. Circulation 1981;64: 744-753. (Pubitemid 11030128)
19. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, Reichek N. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986;57: 450-458. (Pubitemid 16119719)
20. Takeda Y, Sakata Y, Higashimori M, Mano T, Nishio M, Ohtani T, Hori M, Masuyama T, Kaneko M, Yamamoto K. Noninvasive assessment of wall distensibility with the evaluation of diastolic epicardial movement. J Card Fail 2009;15: 68-77.
21. Yamagami H, Kitagawa K, Hoshi T, Furukado S, Hougaku H, Nagai Y, Hori M. Association of serum IL-18 levels with carotid intima-media thickness. Arterioscler Thromb Vasc Biol 2005;25: 1458-1462. (Pubitemid 40923368)
22. Kondo K, Kitagawa K, Nagai Y, Yamagami H, Hashimoto H, Hougaku H, Hori M. Association of soluble intercellular adhesion molecule-1 with carotid atherosclerosis progression. Atherosclerosis 2005;179: 155-160. (Pubitemid 40249798)
23. Yamamoto K, Redfield MM, Nishimura RA. Analysis of left ventricular diastolic function. Heart 1996;75(Suppl 2): 27-35. (Pubitemid 26183700)
24. Yamamoto K, Burnett Jr JC, Jougasaki M, Nishimura RA, Bailey KR, Saito Y, Nakao K, Redfield MM. Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy. Hypertension 1996;28: 988-994. (Pubitemid 26415815)
25. Solomon SD, Janardhanan R, Verma A, Bourgoun M, Daley WL, Purkayastha D, Lacourcière Y, Hippler SE, Fields H, Naqvi TZ, Mulvagh SL, Arnold JM, Thomas JD, Zile MR, Aurigemma GP. Effect of angiotensin receptor blockade and antihypertensive drugs on diastolic function in patients with hypertension and diastolic dysfunction: a randomised trial. Lancet 2007;369: 2079-2087. (Pubitemid 46935945)
26. Yamamoto K, Masuyama T, Sakata Y, Mano T, Nishikawa H, Kondo H, Akehi N, Kuzuya T, Miwa T, Hori M. Role of renin-angiotensin and endothelin systems in development of diastolic heart failure in hypertensive hearts. Cardiovasc Res 2000;47: 274-283. (Pubitemid 30625290)
27. Yamamoto K, Mano T, Yoshida J, Sakata Y, Nishikawa N, Nishio M, Ohtani T, Hori H, Miwa T, Masuyama T. ACE inhibitor and angiotensin II type 1 receptor blocker differently regulate ventricular fibrosis in hypertensive diastolic heart failure. J Hypertens 2005;23: 393-400. (Pubitemid 40279643)
28. Diez J, Querejeta R, Lopez B, Gonzalez A, Larman M, Martinez Ubago JL. Losartandependent regression of myocardial fibrosis is associated with reduction of left ventricular chamber stiffness in hypertensive patients. Circulation 2002;105: 2512-2517. (Pubitemid 34568973)
29. Hashimoto H, Kitagawa K, Hougaku H, Shimizu Y, Sakaguchi M, Nagai Y, Iyama S, Yamanishi H, Matsumoto M, Hori M. C-reactive protein is an independent predictor of the rate of increase in early carotid atherosclerosis. Circulation 2001;104: 63-67. (Pubitemid 32623290)
30. Gagliardi AC, Miname MH, Santos RD. Uric acid: a marker of increased cardiovascular risk. Atherosclerosis 2009;202: 11-17.
31. Pitt B, Byington RP, Furberg CD, Hunninghake DB, Mancini GB, Miller ME, Riley W. Effect of amlodipine on the progression of atherosclerosis and the occurrence of clinical events. Circulation 2000;102: 1503-1510.
32. Terpstra WF, May JF, Smit AJ, Graeff PA, Meyboom-de Jong B, Crijns HJ. Effects of amlodipine and lisinopril on intima-media thickness in previously untreated, elderly hypertensive patients (the ELVERA trial). J Hypertens 2004;22: 1309-1316. (Pubitemid 38888076)
33. Ludwig M, Stapff M, Ribeiro A, Fritschka E, Tholl U, Smith RD, Stumpe KO. Comparison of the effects of losartan and atenolol on common carotid artery intimamedia thickness in patients with hypertension: results of a 2-year, double-blind, randomized, controlled study. Clin Ther 2002;24: 1175-1193. (Pubitemid 34833239)
34. Olsen MH, Wachtell K, Neland K, Bella JN, Rokkedal J, Dige-Petersen H, Ibsen H. Losartan but not atenolol reduce carotid artery hypertrophy in essential hypertension. A LIFE substudy. Blood Press 2005;14: 177-183. (Pubitemid 41015717)
35. Nakamura T, Inoue T, Suzuki T, Kawagoe Y, Ueda Y, Koide H, Node K. Comparison of renal and vascular protective effects between telmisartan and amlodipine in hypertensive patients with chronic kidney disease with mild renal insufficiency. Hypertens Res 2008;31: 841-850. (Pubitemid 351895027)
36. Ikeda H, Minamikawa J, Nakamura Y, Honjo S, Hamamoto Y, Wada Y, Nabe K, Koshiyama H. Comparison of effects of amlodipine and angiotensin receptor blockers on the intima-media thickness of carotid arterial wall (AAA study: amlodipine vs ARB in atherosclerosis study). Diabetes Res Clin Pract 2009;83: 50-53.
37. Ogihara T, Nakao K, Fukui T, Fukiyama K, Ueshima K, Oba K, Sato T, Saruta T. Effects of candesartan compared with amlodipine in hypertensive patients with high cardiovascular risks: candesartan antihypertensive survival evaluation in Japan trial. Hypertension 2008;51: 393-398. (Pubitemid 351159955)
38. Lopez B, Querejeta R, Varo N, Gonzalez A, Larman M, Martinez Ubago JL, Diez J. Usefulness of serum carboxy-terminal propeptide of procollagen type I in assessment of the cardioreparative ability of antihypertensive treatment in hypertensive patients. Circulation 2001;104: 286-291. (Pubitemid 32666949)
39. Ciulla MM, Paliotti R, Esposito A, Diez J, Lopez B, Dahlof B, Nicholls MG, Smith RD, Gilles L, Magrini F, Zanchetti A. Different effects of antihypertensive therapies based on losartan or atenolol on ultrasound and biochemical markers of myocardial fibrosis: Results of a randomized trial. Circulation 2004;110: 552-557. (Pubitemid 39031172)
40. Devereux RB, Dahlof B, Gerdts E, Boman K, Nieminen MS, Papademetriou V, Rokkedal J, Harris KE, Edelman JM, Wachtell K. Regression of hypertensive left ventricular hypertrophy by losartan compared with atenolol: The losartan intervention for endpoint reduction in hypertension (LIFE) trial. Circulation 2004;110: 1456-1462. (Pubitemid 39238023)